Contrastingly in the study by Shiels et al, MDC was identified as a significant risk factor for lung cancer, that is, patients with elevated MDC levels had a 1.63-fold increased lung cancer risk in discovery phase and a 2.09-folded increased risk in replication phase [11]. This evidence concerns the gene CCL22 and lung cancer.